Global Non-oncology Biopharmaceuticals Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Non-oncology Biopharmaceuticals will have significant change from previous year. According to our (LP Information) latest study, the global Non-oncology Biopharmaceuticals market size is USD million in 2022 from USD 289190 million in 2021, with a change of % between 2021 and 2022. The global Non-oncology Biopharmaceuticals market size will reach USD 515550 million in 2028, growing at a CAGR of 8.6% over the analysis period.
The United States Non-oncology Biopharmaceuticals market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-oncology Biopharmaceuticals market, reaching US$ million by the year 2028. As for the Europe Non-oncology Biopharmaceuticals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-oncology Biopharmaceuticals players cover Roche, Sanofi, Johnson & Johnson, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-oncology Biopharmaceuticals market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Non-oncology Biopharmaceuticals will have significant change from previous year. According to our (LP Information) latest study, the global Non-oncology Biopharmaceuticals market size is USD million in 2022 from USD 289190 million in 2021, with a change of % between 2021 and 2022. The global Non-oncology Biopharmaceuticals market size will reach USD 515550 million in 2028, growing at a CAGR of 8.6% over the analysis period.
The United States Non-oncology Biopharmaceuticals market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-oncology Biopharmaceuticals market, reaching US$ million by the year 2028. As for the Europe Non-oncology Biopharmaceuticals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-oncology Biopharmaceuticals players cover Roche, Sanofi, Johnson & Johnson, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-oncology Biopharmaceuticals market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Biologics
- Biosimilars
- Immunology
- Endocrinology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Novartis
- Merck
- Teva
- Eli Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- UCB Pharma
- Amgen
- AbbVie
- Takeda
- AstraZeneca
- Mylan
- LEO Pharma
- Boehringer Ingelheim
- Alexion Pharmaceuticals
- Elusys Therapeutics
- Swedish Orphan Biovitrum
- Biogen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-oncology Biopharmaceuticals Market Size 2017-2028
2.1.2 Non-oncology Biopharmaceuticals Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-oncology Biopharmaceuticals Segment by Type
2.2.1 Biologics
2.2.2 Biosimilars
2.3 Non-oncology Biopharmaceuticals Market Size by Type
2.3.1 Non-oncology Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
2.4 Non-oncology Biopharmaceuticals Segment by Application
2.4.1 Immunology
2.4.2 Endocrinology
2.4.3 Others
2.5 Non-oncology Biopharmaceuticals Market Size by Application
2.5.1 Non-oncology Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
3 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SIZE BY PLAYER
3.1 Non-oncology Biopharmaceuticals Market Size Market Share by Players
3.1.1 Global Non-oncology Biopharmaceuticals Revenue by Players (2020-2022)
3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Players (2020-2022)
3.2 Global Non-oncology Biopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY BIOPHARMACEUTICALS BY REGIONS
4.1 Non-oncology Biopharmaceuticals Market Size by Regions (2017-2022)
4.2 Americas Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
4.3 APAC Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
4.4 Europe Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)
5.2 Americas Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
5.3 Americas Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-oncology Biopharmaceuticals Market Size by Region (2017-2022)
6.2 APAC Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
6.3 APAC Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-oncology Biopharmaceuticals by Country (2017-2022)
7.2 Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
7.3 Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-oncology Biopharmaceuticals by Region (2017-2022)
8.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-ONCOLOGY BIOPHARMACEUTICALS MARKET FORECAST
10.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2023-2028)
10.1.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2023-2028)
10.1.2 Americas Non-oncology Biopharmaceuticals Forecast
10.1.3 APAC Non-oncology Biopharmaceuticals Forecast
10.1.4 Europe Non-oncology Biopharmaceuticals Forecast
10.1.5 Middle East & Africa Non-oncology Biopharmaceuticals Forecast
10.2 Americas Non-oncology Biopharmaceuticals Forecast by Country (2023-2028)
10.2.1 United States Non-oncology Biopharmaceuticals Market Forecast
10.2.2 Canada Non-oncology Biopharmaceuticals Market Forecast
10.2.3 Mexico Non-oncology Biopharmaceuticals Market Forecast
10.2.4 Brazil Non-oncology Biopharmaceuticals Market Forecast
10.3 APAC Non-oncology Biopharmaceuticals Forecast by Region (2023-2028)
10.3.1 China Non-oncology Biopharmaceuticals Market Forecast
10.3.2 Japan Non-oncology Biopharmaceuticals Market Forecast
10.3.3 Korea Non-oncology Biopharmaceuticals Market Forecast
10.3.4 Southeast Asia Non-oncology Biopharmaceuticals Market Forecast
10.3.5 India Non-oncology Biopharmaceuticals Market Forecast
10.3.6 Australia Non-oncology Biopharmaceuticals Market Forecast
10.4 Europe Non-oncology Biopharmaceuticals Forecast by Country (2023-2028)
10.4.1 Germany Non-oncology Biopharmaceuticals Market Forecast
10.4.2 France Non-oncology Biopharmaceuticals Market Forecast
10.4.3 UK Non-oncology Biopharmaceuticals Market Forecast
10.4.4 Italy Non-oncology Biopharmaceuticals Market Forecast
10.4.5 Russia Non-oncology Biopharmaceuticals Market Forecast
10.5 Middle East & Africa Non-oncology Biopharmaceuticals Forecast by Region (2023-2028)
10.5.1 Egypt Non-oncology Biopharmaceuticals Market Forecast
10.5.2 South Africa Non-oncology Biopharmaceuticals Market Forecast
10.5.3 Israel Non-oncology Biopharmaceuticals Market Forecast
10.5.4 Turkey Non-oncology Biopharmaceuticals Market Forecast
10.5.5 GCC Countries Non-oncology Biopharmaceuticals Market Forecast
10.6 Global Non-oncology Biopharmaceuticals Forecast by Type (2023-2028)
10.7 Global Non-oncology Biopharmaceuticals Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Non-oncology Biopharmaceuticals Product Offered
11.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Non-oncology Biopharmaceuticals Product Offered
11.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Non-oncology Biopharmaceuticals Product Offered
11.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Non-oncology Biopharmaceuticals Product Offered
11.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Information
11.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Offered
11.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novo Nordisk Main Business Overview
11.5.5 Novo Nordisk Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Non-oncology Biopharmaceuticals Product Offered
11.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Non-oncology Biopharmaceuticals Product Offered
11.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Teva
11.8.1 Teva Company Information
11.8.2 Teva Non-oncology Biopharmaceuticals Product Offered
11.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Teva Main Business Overview
11.8.5 Teva Latest Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Offered
11.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Eli Lilly Main Business Overview
11.9.5 Eli Lilly Latest Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Information
11.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offered
11.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Bristol-Myers Squibb Main Business Overview
11.10.5 Bristol-Myers Squibb Latest Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offered
11.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 UCB Pharma
11.12.1 UCB Pharma Company Information
11.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Offered
11.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 UCB Pharma Main Business Overview
11.12.5 UCB Pharma Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Non-oncology Biopharmaceuticals Product Offered
11.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 AbbVie
11.14.1 AbbVie Company Information
11.14.2 AbbVie Non-oncology Biopharmaceuticals Product Offered
11.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 AbbVie Main Business Overview
11.14.5 AbbVie Latest Developments
11.15 Takeda
11.15.1 Takeda Company Information
11.15.2 Takeda Non-oncology Biopharmaceuticals Product Offered
11.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Takeda Main Business Overview
11.15.5 Takeda Latest Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Company Information
11.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Offered
11.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 AstraZeneca Main Business Overview
11.16.5 AstraZeneca Latest Developments
11.17 Mylan
11.17.1 Mylan Company Information
11.17.2 Mylan Non-oncology Biopharmaceuticals Product Offered
11.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Mylan Main Business Overview
11.17.5 Mylan Latest Developments
11.18 LEO Pharma
11.18.1 LEO Pharma Company Information
11.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Offered
11.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 LEO Pharma Main Business Overview
11.18.5 LEO Pharma Latest Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offered
11.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Boehringer Ingelheim Main Business Overview
11.19.5 Boehringer Ingelheim Latest Developments
11.20 Alexion Pharmaceuticals
11.20.1 Alexion Pharmaceuticals Company Information
11.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offered
11.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Alexion Pharmaceuticals Main Business Overview
11.20.5 Alexion Pharmaceuticals Latest Developments
11.21 Elusys Therapeutics
11.21.1 Elusys Therapeutics Company Information
11.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offered
11.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Elusys Therapeutics Main Business Overview
11.21.5 Elusys Therapeutics Latest Developments
11.22 Swedish Orphan Biovitrum
11.22.1 Swedish Orphan Biovitrum Company Information
11.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offered
11.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Swedish Orphan Biovitrum Main Business Overview
11.22.5 Swedish Orphan Biovitrum Latest Developments
11.23 Biogen
11.23.1 Biogen Company Information
11.23.2 Biogen Non-oncology Biopharmaceuticals Product Offered
11.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Biogen Main Business Overview
11.23.5 Biogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-oncology Biopharmaceuticals Market Size 2017-2028
2.1.2 Non-oncology Biopharmaceuticals Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-oncology Biopharmaceuticals Segment by Type
2.2.1 Biologics
2.2.2 Biosimilars
2.3 Non-oncology Biopharmaceuticals Market Size by Type
2.3.1 Non-oncology Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
2.4 Non-oncology Biopharmaceuticals Segment by Application
2.4.1 Immunology
2.4.2 Endocrinology
2.4.3 Others
2.5 Non-oncology Biopharmaceuticals Market Size by Application
2.5.1 Non-oncology Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
3 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SIZE BY PLAYER
3.1 Non-oncology Biopharmaceuticals Market Size Market Share by Players
3.1.1 Global Non-oncology Biopharmaceuticals Revenue by Players (2020-2022)
3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Players (2020-2022)
3.2 Global Non-oncology Biopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY BIOPHARMACEUTICALS BY REGIONS
4.1 Non-oncology Biopharmaceuticals Market Size by Regions (2017-2022)
4.2 Americas Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
4.3 APAC Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
4.4 Europe Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-oncology Biopharmaceuticals Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)
5.2 Americas Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
5.3 Americas Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-oncology Biopharmaceuticals Market Size by Region (2017-2022)
6.2 APAC Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
6.3 APAC Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-oncology Biopharmaceuticals by Country (2017-2022)
7.2 Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
7.3 Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-oncology Biopharmaceuticals by Region (2017-2022)
8.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-ONCOLOGY BIOPHARMACEUTICALS MARKET FORECAST
10.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2023-2028)
10.1.1 Global Non-oncology Biopharmaceuticals Forecast by Regions (2023-2028)
10.1.2 Americas Non-oncology Biopharmaceuticals Forecast
10.1.3 APAC Non-oncology Biopharmaceuticals Forecast
10.1.4 Europe Non-oncology Biopharmaceuticals Forecast
10.1.5 Middle East & Africa Non-oncology Biopharmaceuticals Forecast
10.2 Americas Non-oncology Biopharmaceuticals Forecast by Country (2023-2028)
10.2.1 United States Non-oncology Biopharmaceuticals Market Forecast
10.2.2 Canada Non-oncology Biopharmaceuticals Market Forecast
10.2.3 Mexico Non-oncology Biopharmaceuticals Market Forecast
10.2.4 Brazil Non-oncology Biopharmaceuticals Market Forecast
10.3 APAC Non-oncology Biopharmaceuticals Forecast by Region (2023-2028)
10.3.1 China Non-oncology Biopharmaceuticals Market Forecast
10.3.2 Japan Non-oncology Biopharmaceuticals Market Forecast
10.3.3 Korea Non-oncology Biopharmaceuticals Market Forecast
10.3.4 Southeast Asia Non-oncology Biopharmaceuticals Market Forecast
10.3.5 India Non-oncology Biopharmaceuticals Market Forecast
10.3.6 Australia Non-oncology Biopharmaceuticals Market Forecast
10.4 Europe Non-oncology Biopharmaceuticals Forecast by Country (2023-2028)
10.4.1 Germany Non-oncology Biopharmaceuticals Market Forecast
10.4.2 France Non-oncology Biopharmaceuticals Market Forecast
10.4.3 UK Non-oncology Biopharmaceuticals Market Forecast
10.4.4 Italy Non-oncology Biopharmaceuticals Market Forecast
10.4.5 Russia Non-oncology Biopharmaceuticals Market Forecast
10.5 Middle East & Africa Non-oncology Biopharmaceuticals Forecast by Region (2023-2028)
10.5.1 Egypt Non-oncology Biopharmaceuticals Market Forecast
10.5.2 South Africa Non-oncology Biopharmaceuticals Market Forecast
10.5.3 Israel Non-oncology Biopharmaceuticals Market Forecast
10.5.4 Turkey Non-oncology Biopharmaceuticals Market Forecast
10.5.5 GCC Countries Non-oncology Biopharmaceuticals Market Forecast
10.6 Global Non-oncology Biopharmaceuticals Forecast by Type (2023-2028)
10.7 Global Non-oncology Biopharmaceuticals Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Non-oncology Biopharmaceuticals Product Offered
11.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Non-oncology Biopharmaceuticals Product Offered
11.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Non-oncology Biopharmaceuticals Product Offered
11.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Non-oncology Biopharmaceuticals Product Offered
11.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Information
11.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Offered
11.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novo Nordisk Main Business Overview
11.5.5 Novo Nordisk Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Non-oncology Biopharmaceuticals Product Offered
11.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Non-oncology Biopharmaceuticals Product Offered
11.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Teva
11.8.1 Teva Company Information
11.8.2 Teva Non-oncology Biopharmaceuticals Product Offered
11.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Teva Main Business Overview
11.8.5 Teva Latest Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Offered
11.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Eli Lilly Main Business Overview
11.9.5 Eli Lilly Latest Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Information
11.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offered
11.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Bristol-Myers Squibb Main Business Overview
11.10.5 Bristol-Myers Squibb Latest Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Information
11.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offered
11.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 GlaxoSmithKline Main Business Overview
11.11.5 GlaxoSmithKline Latest Developments
11.12 UCB Pharma
11.12.1 UCB Pharma Company Information
11.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Offered
11.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 UCB Pharma Main Business Overview
11.12.5 UCB Pharma Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Non-oncology Biopharmaceuticals Product Offered
11.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 AbbVie
11.14.1 AbbVie Company Information
11.14.2 AbbVie Non-oncology Biopharmaceuticals Product Offered
11.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 AbbVie Main Business Overview
11.14.5 AbbVie Latest Developments
11.15 Takeda
11.15.1 Takeda Company Information
11.15.2 Takeda Non-oncology Biopharmaceuticals Product Offered
11.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Takeda Main Business Overview
11.15.5 Takeda Latest Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Company Information
11.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Offered
11.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 AstraZeneca Main Business Overview
11.16.5 AstraZeneca Latest Developments
11.17 Mylan
11.17.1 Mylan Company Information
11.17.2 Mylan Non-oncology Biopharmaceuticals Product Offered
11.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Mylan Main Business Overview
11.17.5 Mylan Latest Developments
11.18 LEO Pharma
11.18.1 LEO Pharma Company Information
11.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Offered
11.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 LEO Pharma Main Business Overview
11.18.5 LEO Pharma Latest Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offered
11.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Boehringer Ingelheim Main Business Overview
11.19.5 Boehringer Ingelheim Latest Developments
11.20 Alexion Pharmaceuticals
11.20.1 Alexion Pharmaceuticals Company Information
11.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offered
11.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Alexion Pharmaceuticals Main Business Overview
11.20.5 Alexion Pharmaceuticals Latest Developments
11.21 Elusys Therapeutics
11.21.1 Elusys Therapeutics Company Information
11.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offered
11.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Elusys Therapeutics Main Business Overview
11.21.5 Elusys Therapeutics Latest Developments
11.22 Swedish Orphan Biovitrum
11.22.1 Swedish Orphan Biovitrum Company Information
11.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offered
11.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Swedish Orphan Biovitrum Main Business Overview
11.22.5 Swedish Orphan Biovitrum Latest Developments
11.23 Biogen
11.23.1 Biogen Company Information
11.23.2 Biogen Non-oncology Biopharmaceuticals Product Offered
11.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Biogen Main Business Overview
11.23.5 Biogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-oncology Biopharmaceuticals Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Biologics
Table 3. Major Players of Biosimilars
Table 4. Non-oncology Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 7. Non-oncology Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 10. Global Non-oncology Biopharmaceuticals Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Non-oncology Biopharmaceuticals Revenue Market Share by Player (2020-2022)
Table 12. Non-oncology Biopharmaceuticals Key Players Head office and Products Offered
Table 13. Non-oncology Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Non-oncology Biopharmaceuticals Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Non-oncology Biopharmaceuticals Market Size Market Share by Regions (2017-2022)
Table 18. Americas Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Country (2017-2022)
Table 20. Americas Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 22. Americas Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 24. APAC Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Region (2017-2022)
Table 26. APAC Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 28. APAC Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 30. Europe Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Country (2017-2022)
Table 32. Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 34. Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Non-oncology Biopharmaceuticals
Table 43. Key Market Challenges & Risks of Non-oncology Biopharmaceuticals
Table 44. Key Industry Trends of Non-oncology Biopharmaceuticals
Table 45. Global Non-oncology Biopharmaceuticals Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 52. Roche Non-oncology Biopharmaceuticals Product Offered
Table 53. Roche Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Sanofi Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 57. Sanofi Non-oncology Biopharmaceuticals Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Sanofi Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 62. Johnson & Johnson Non-oncology Biopharmaceuticals Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Johnson & Johnson Latest Developments
Table 66. Pfizer Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 67. Pfizer Non-oncology Biopharmaceuticals Product Offered
Table 68. Pfizer Main Business
Table 69. Pfizer Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Pfizer Latest Developments
Table 71. Novo Nordisk Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 72. Novo Nordisk Non-oncology Biopharmaceuticals Product Offered
Table 73. Novo Nordisk Main Business
Table 74. Novo Nordisk Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Novo Nordisk Latest Developments
Table 76. Novartis Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 77. Novartis Non-oncology Biopharmaceuticals Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Novartis Latest Developments
Table 81. Merck Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 82. Merck Non-oncology Biopharmaceuticals Product Offered
Table 83. Merck Main Business
Table 84. Merck Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Merck Latest Developments
Table 86. Teva Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 87. Teva Non-oncology Biopharmaceuticals Product Offered
Table 88. Teva Main Business
Table 89. Teva Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Teva Latest Developments
Table 91. Eli Lilly Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 92. Eli Lilly Non-oncology Biopharmaceuticals Product Offered
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Eli Lilly Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. GlaxoSmithKline Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 102. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offered
Table 103. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. GlaxoSmithKline Main Business
Table 105. GlaxoSmithKline Latest Developments
Table 106. UCB Pharma Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 107. UCB Pharma Non-oncology Biopharmaceuticals Product Offered
Table 108. UCB Pharma Main Business
Table 109. UCB Pharma Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. UCB Pharma Latest Developments
Table 111. Amgen Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 112. Amgen Non-oncology Biopharmaceuticals Product Offered
Table 113. Amgen Main Business
Table 114. Amgen Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Amgen Latest Developments
Table 116. AbbVie Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 117. AbbVie Non-oncology Biopharmaceuticals Product Offered
Table 118. AbbVie Main Business
Table 119. AbbVie Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. AbbVie Latest Developments
Table 121. Takeda Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 122. Takeda Non-oncology Biopharmaceuticals Product Offered
Table 123. Takeda Main Business
Table 124. Takeda Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Takeda Latest Developments
Table 126. AstraZeneca Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 127. AstraZeneca Non-oncology Biopharmaceuticals Product Offered
Table 128. AstraZeneca Main Business
Table 129. AstraZeneca Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. AstraZeneca Latest Developments
Table 131. Mylan Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 132. Mylan Non-oncology Biopharmaceuticals Product Offered
Table 133. Mylan Main Business
Table 134. Mylan Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Mylan Latest Developments
Table 136. LEO Pharma Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 137. LEO Pharma Non-oncology Biopharmaceuticals Product Offered
Table 138. LEO Pharma Main Business
Table 139. LEO Pharma Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. LEO Pharma Latest Developments
Table 141. Boehringer Ingelheim Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 142. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offered
Table 143. Boehringer Ingelheim Main Business
Table 144. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Boehringer Ingelheim Latest Developments
Table 146. Alexion Pharmaceuticals Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 147. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offered
Table 148. Alexion Pharmaceuticals Main Business
Table 149. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Alexion Pharmaceuticals Latest Developments
Table 151. Elusys Therapeutics Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 152. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offered
Table 153. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Elusys Therapeutics Main Business
Table 155. Elusys Therapeutics Latest Developments
Table 156. Swedish Orphan Biovitrum Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 157. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offered
Table 158. Swedish Orphan Biovitrum Main Business
Table 159. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Swedish Orphan Biovitrum Latest Developments
Table 161. Biogen Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 162. Biogen Non-oncology Biopharmaceuticals Product Offered
Table 163. Biogen Main Business
Table 164. Biogen Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 165. Biogen Latest Developments
Table 1. Non-oncology Biopharmaceuticals Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Biologics
Table 3. Major Players of Biosimilars
Table 4. Non-oncology Biopharmaceuticals Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 7. Non-oncology Biopharmaceuticals Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 10. Global Non-oncology Biopharmaceuticals Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Non-oncology Biopharmaceuticals Revenue Market Share by Player (2020-2022)
Table 12. Non-oncology Biopharmaceuticals Key Players Head office and Products Offered
Table 13. Non-oncology Biopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Non-oncology Biopharmaceuticals Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Non-oncology Biopharmaceuticals Market Size Market Share by Regions (2017-2022)
Table 18. Americas Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Country (2017-2022)
Table 20. Americas Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 22. Americas Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 24. APAC Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Region (2017-2022)
Table 26. APAC Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 28. APAC Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 30. Europe Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Country (2017-2022)
Table 32. Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 34. Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Non-oncology Biopharmaceuticals
Table 43. Key Market Challenges & Risks of Non-oncology Biopharmaceuticals
Table 44. Key Industry Trends of Non-oncology Biopharmaceuticals
Table 45. Global Non-oncology Biopharmaceuticals Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Non-oncology Biopharmaceuticals Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 52. Roche Non-oncology Biopharmaceuticals Product Offered
Table 53. Roche Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Sanofi Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 57. Sanofi Non-oncology Biopharmaceuticals Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Sanofi Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 62. Johnson & Johnson Non-oncology Biopharmaceuticals Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Johnson & Johnson Latest Developments
Table 66. Pfizer Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 67. Pfizer Non-oncology Biopharmaceuticals Product Offered
Table 68. Pfizer Main Business
Table 69. Pfizer Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Pfizer Latest Developments
Table 71. Novo Nordisk Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 72. Novo Nordisk Non-oncology Biopharmaceuticals Product Offered
Table 73. Novo Nordisk Main Business
Table 74. Novo Nordisk Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Novo Nordisk Latest Developments
Table 76. Novartis Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 77. Novartis Non-oncology Biopharmaceuticals Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Novartis Latest Developments
Table 81. Merck Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 82. Merck Non-oncology Biopharmaceuticals Product Offered
Table 83. Merck Main Business
Table 84. Merck Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Merck Latest Developments
Table 86. Teva Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 87. Teva Non-oncology Biopharmaceuticals Product Offered
Table 88. Teva Main Business
Table 89. Teva Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Teva Latest Developments
Table 91. Eli Lilly Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 92. Eli Lilly Non-oncology Biopharmaceuticals Product Offered
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Eli Lilly Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. GlaxoSmithKline Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 102. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offered
Table 103. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. GlaxoSmithKline Main Business
Table 105. GlaxoSmithKline Latest Developments
Table 106. UCB Pharma Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 107. UCB Pharma Non-oncology Biopharmaceuticals Product Offered
Table 108. UCB Pharma Main Business
Table 109. UCB Pharma Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. UCB Pharma Latest Developments
Table 111. Amgen Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 112. Amgen Non-oncology Biopharmaceuticals Product Offered
Table 113. Amgen Main Business
Table 114. Amgen Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Amgen Latest Developments
Table 116. AbbVie Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 117. AbbVie Non-oncology Biopharmaceuticals Product Offered
Table 118. AbbVie Main Business
Table 119. AbbVie Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. AbbVie Latest Developments
Table 121. Takeda Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 122. Takeda Non-oncology Biopharmaceuticals Product Offered
Table 123. Takeda Main Business
Table 124. Takeda Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Takeda Latest Developments
Table 126. AstraZeneca Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 127. AstraZeneca Non-oncology Biopharmaceuticals Product Offered
Table 128. AstraZeneca Main Business
Table 129. AstraZeneca Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. AstraZeneca Latest Developments
Table 131. Mylan Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 132. Mylan Non-oncology Biopharmaceuticals Product Offered
Table 133. Mylan Main Business
Table 134. Mylan Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Mylan Latest Developments
Table 136. LEO Pharma Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 137. LEO Pharma Non-oncology Biopharmaceuticals Product Offered
Table 138. LEO Pharma Main Business
Table 139. LEO Pharma Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. LEO Pharma Latest Developments
Table 141. Boehringer Ingelheim Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 142. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offered
Table 143. Boehringer Ingelheim Main Business
Table 144. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Boehringer Ingelheim Latest Developments
Table 146. Alexion Pharmaceuticals Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 147. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offered
Table 148. Alexion Pharmaceuticals Main Business
Table 149. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Alexion Pharmaceuticals Latest Developments
Table 151. Elusys Therapeutics Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 152. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offered
Table 153. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 154. Elusys Therapeutics Main Business
Table 155. Elusys Therapeutics Latest Developments
Table 156. Swedish Orphan Biovitrum Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 157. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offered
Table 158. Swedish Orphan Biovitrum Main Business
Table 159. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Swedish Orphan Biovitrum Latest Developments
Table 161. Biogen Details, Company Type, Non-oncology Biopharmaceuticals Area Served and Its Competitors
Table 162. Biogen Non-oncology Biopharmaceuticals Product Offered
Table 163. Biogen Main Business
Table 164. Biogen Non-oncology Biopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 165. Biogen Latest Developments
LIST OF FIGURES
Figure 1. Non-oncology Biopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-oncology Biopharmaceuticals Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021
Figure 7. Non-oncology Biopharmaceuticals in Immunology
Figure 8. Global Non-oncology Biopharmaceuticals Market: Immunology (2017-2022) & ($ Millions)
Figure 9. Non-oncology Biopharmaceuticals in Endocrinology
Figure 10. Global Non-oncology Biopharmaceuticals Market: Endocrinology (2017-2022) & ($ Millions)
Figure 11. Non-oncology Biopharmaceuticals in Others
Figure 12. Global Non-oncology Biopharmaceuticals Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 14. Global Non-oncology Biopharmaceuticals Revenue Market Share by Player in 2021
Figure 15. Global Non-oncology Biopharmaceuticals Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 17. APAC Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 18. Europe Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 20. Americas Non-oncology Biopharmaceuticals Value Market Share by Country in 2021
Figure 21. Americas Non-oncology Biopharmaceuticals Consumption Market Share by Type in 2021
Figure 22. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 23. United States Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Region in 2021
Figure 28. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 29. China Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Country in 2021
Figure 36. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021
Figure 37. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 38. Germany Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 46. Egypt Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 52. APAC Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 53. Europe Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 55. United States Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 56. Canada Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 59. China Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 60. Japan Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 61. Korea Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 63. India Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 64. Australia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 65. Germany Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 66. France Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 67. UK Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 68. Italy Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 69. Russia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 70. Spain Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 73. Israel Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 1. Non-oncology Biopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-oncology Biopharmaceuticals Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021
Figure 7. Non-oncology Biopharmaceuticals in Immunology
Figure 8. Global Non-oncology Biopharmaceuticals Market: Immunology (2017-2022) & ($ Millions)
Figure 9. Non-oncology Biopharmaceuticals in Endocrinology
Figure 10. Global Non-oncology Biopharmaceuticals Market: Endocrinology (2017-2022) & ($ Millions)
Figure 11. Non-oncology Biopharmaceuticals in Others
Figure 12. Global Non-oncology Biopharmaceuticals Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 14. Global Non-oncology Biopharmaceuticals Revenue Market Share by Player in 2021
Figure 15. Global Non-oncology Biopharmaceuticals Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 17. APAC Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 18. Europe Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Non-oncology Biopharmaceuticals Market Size 2017-2022 ($ Millions)
Figure 20. Americas Non-oncology Biopharmaceuticals Value Market Share by Country in 2021
Figure 21. Americas Non-oncology Biopharmaceuticals Consumption Market Share by Type in 2021
Figure 22. Americas Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 23. United States Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Region in 2021
Figure 28. APAC Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 29. China Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Country in 2021
Figure 36. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021
Figure 37. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 38. Germany Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application in 2021
Figure 46. Egypt Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Non-oncology Biopharmaceuticals Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 52. APAC Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 53. Europe Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 55. United States Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 56. Canada Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 59. China Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 60. Japan Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 61. Korea Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 63. India Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 64. Australia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 65. Germany Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 66. France Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 67. UK Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 68. Italy Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 69. Russia Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 70. Spain Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 73. Israel Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Non-oncology Biopharmaceuticals Market Size 2023-2028 ($ Millions)
